Related Experiment Video
Updated: Jul 4, 2025

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
Iron deficiency and supplementation in heart failure
Samira Lakhal-Littleton1, John G F Cleland2
1Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, UK. samira.lakhal-littleton@dpag.ox.ac.uk.
Non-anaemic iron deficiency (NAID) in heart failure presents challenges due to complex iron homeostasis. Current definitions and therapies are insufficient, necessitating refined strategies for better patient outcomes.
Area of Science:
- Cardiovascular Medicine
- Iron Homeostasis
- Nutritional Deficiencies
Background:
- Non-anaemic iron deficiency (NAID) is linked to adverse outcomes in cardiovascular disease.
- Existing treatments for NAID in heart failure show inconsistent results, highlighting knowledge gaps.
Purpose of the Study:
- To re-evaluate the definition of iron deficiency in heart failure patients.
- To understand the impact of iron homeostasis mechanisms outside red blood cell production on NAID management.
- To identify improved strategies for iron supplementation in heart failure.
Main Methods:
- Integration of clinical and preclinical evidence.
- Analysis of iron homeostasis mechanisms beyond erythropoiesis.
- Review of current definitions and therapeutic approaches for NAID in heart failure.
Main Results:
- Current definitions of iron deficiency in heart failure are inadequate, failing to identify all patients with unmet iron needs.
- Iron supplementation benefits vary among heart failure patients due to differing needs and the influence of anemia and inflammation on iron metabolism.
- The study highlights the complexity of iron handling in heart failure.
Conclusions:
- Refined definitions and personalized iron therapies are needed for effective NAID management in heart failure.
- Understanding non-erythron iron regulation is crucial for optimizing treatment.
- Findings may inform NAID management in other chronic diseases like CKD, COPD, and cancer.
More Related Videos
04:48Setup of Capillary Electrophoresis-Inductively Coupled Plasma Mass Spectrometry CE-ICP-MS for Quantification of Iron Redox Species FeII, FeIII
Published on: May 4, 2020
05:23Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Heart Failure Drugs: Inotropic Agents
Pathophysiology of Heart Failure
Heart Failure Drugs: Diuretics
Heart Failure Drugs: β-Blockers
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...